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ABSTRACT
Hematopoietic stem cells (HSCs) are unique in their ability to self-renew and 
differentiate into all mature blood lineages. The equilibrium between these 
processes is crucial for tissue maintenance during the lifetime of the organism. 
However, with age the functionality of HSCs declines, resulting in development 
of anemias, deficiencies of immune response and increased risk of hematopoi-
etic malignancies. Aged HSCs are characterized by preferential differentiation 
towards myeloid lineage, impaired self-renewal and engraftment. Recent ev-
idence provides clues to the understanding of these processes on cellular and 
molecular levels. Key components contributing to stem cell aging are shifts in 
the transcriptome and epigenome, accompanied by dysfunction of DNA repair 
pathways. In this chapter we will focus on studies and conceptual models of 
murine HSC aging.
INTRODUCTION
Organismal aging is associated with functional decline of many tissues. In the 
hematopoietic system, aging is associated with a decreased immune response, 
an increased incidence of hematopoietic cancers, anemia, and several autoim-
mune disorders (1). A growing body of data supports the notion that at least 
some of these changes originate from dysfunctional hematopoietic stem cells 
(HSCs). Functional decline of HSCs is believed to be orchestrated by the in-
terplay between cell-intrinsic and cell-extrinsic factors. Insight into the mech-
anism underlying HSC aging can be obtained from molecular studies in mice. 
This chapter provides an overview of our current understanding of the mecha-
nisms of murine HSC aging. 
CHARACTERISTICS OF MURINE HSCS
In the mouse, HSCs constitute a small proportion (< 0.01%) of all bone mar-
row cells. However, their extensive proliferative capacity ensures a daily produc-
tion of over 1011 blood cells (2). All types of mature hematopoietic and immune 
cells are generated and regenerated by HSCs, in an intricate process of step-wise 
gradual differentiation (Figure 1). The abilities to self-renew and to differentiate 
into multiple lineages are the defining properties of the HSCs (also see Box 1). 
Morphologically, HSCs cannot be discriminated from more differentiated 
progenitor cells (Figure 1). However, a panel of cell surface markers, characteris-
tically expressed on HSCs, has been identified. These include expression of Sca1, 
c-Kit, CD150 (one of the SLAM markers), CD201 (EPCR), and lack of the ex-
pression of lineage surface markers CD48, CD244, Flt3 and CD34. Alternatively, 
the ability of HSCs to efflux certain dyes (Rhodamine-123 (Rho) and Hoechst 
33342) can be also used for purification (3,4). This feature of HSC results from 
the expression of the ABC-transporters P-glycoprotein and Abcg2 (5). Hoechst 
33342 exclusion results in a characteristic appearance of primitive cells during 
fluorescence-activated cell sorting (FACS), known as the “side population” (SP) 
(6). A combination of multiple of these markers allows prospective isolation and 
characterization of HSCs with purity up to 50%, defined by the ability of a single 
cell to reconstitute hematopoiesis of a lethally irradiated animal (7-11). 
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BOX 1
Hematopoietic stem cell – adult multipotent stem cell that is able to self-renew and differenti-
ate into all mature types of immune and hematopoietic cells.
Functionally defined HSC – a cell that can support long-term robust multilineage repopulation 
of a host, whose own hematopoietic system was ablated (e.g. by irradiation). This definition is 
retrospective. Criteria for defining stemness differ from lab to lab and are based on either total 
donor cell presence (chimerism) in blood of transplant recipient, or chimerism in specific ma-
ture blood populations. The time-scale for defining long-term repopulation varies, but usually 
constitutes at least 4 months of activity after transplantation. A very common functional HSC 
definition is its ability to support production at least 1% of myeloid and lymphoid cells for four 
months after transplantation.
Phenotypically defined HSC – hematopoietic cell expressing a panel of cell surface markers 
characteristic for HSCs. Phenotypic definitions of HSCs become more and more stringent 
over the years, coinciding with discoveries of novel markers. Marker combinations allowing to 
achieve isolation of highly enriched HSC populations include among others
CD150+CD244−CD48−  (SLAM) (7), CD45mid  Rho-  SP (8), LSKCD34-CD150+  (37), lineage-
Sca1+ c-Kit+ (LSK) CD48− CD34− EPCR+ CD150+ (9), CD45+ EPCR+ CD48- CD150+ (ESLAM) 
(78), SP LSK (34). CD45 is expressed on hematopoietic cells and allows to distinguish them 
from non-hematopoietic populations.
HSC clone – all progeny of a single HSC
Clone size – proportion of differentiated cells in blood generated by an HSC clone 
Aging has been shown to increase both the relative frequency and the ab-
solute number of HSCs in the bone marrow of C57BL/6 mice. Initial studies 
using unfractionated bone marrow cells had demonstrated a competitive ad-
vantage of old cells when co-transplanted with equal numbers of young cells 
(12), which was attributed to higher concentrations of repopulating cells in 
the aged population (13). More recent studies, using different combinations of 
phenotypic markers, confirmed a remarkable increase in the pool size of HSC 
upon aging (9,14-16). An example of such a phenotypic increase of primitive 
hematopoietic population upon aging is shown in Figure 2. The extent of such 
expansion was 7- to 16-fold (17). Furthermore, while the frequency of HSCs is 
similar among individual young mice, HSC frequencies become highly variable 
in old mice, indicating a possible loss of control of HSC pool size with age (9). 
Despite many advances that have been made in the identification of the 
phenotype of HSC, “stemness” of a (murine) HSC can only be demonstrated 
retrospectively by its ability for robust multilineage repopulation of a myeloab-
Figure 1. Simplified representation of hematopoietic hierarchy and effects of aging (adapted from 
Verovskaya and de Haan (90)). HSCs residing in the bone marrow produce all the mature hemato-
poietic and immune cells that are found in the blood. The majority of HSCs resides in a quiescent G0 
state (top left) and becomes activated into cycling and differentiation. During the gradual process of 
multilineage differentiation, HSCs lose the ability to self-renew (as indicated by round arrows), and 
become more committed to a certain lineage. In aged mice, HSCs have been found to more actively 
cycle. Moreover, hematopoiesis becomes skewed towards production of myeloid cells while lym-
phoid production becomes deficient. Regeneration of red blood cells and platelets is also decreased 
with lifespan. Processes activated with age are indicated with red arrows, while decreased activity 
is depicted with blue arrows. LT-HSCs indicate long-term repopulating HSC, ST-HSCs – short-term 
repopulating HSCs. Several described intermediate progenitor states are shown on the figure: MPP 
– multipotent progenitor cells, LMPP – lymphoid-primed multipotent progenitors, CMP – common 
myeloid progenitors, CLP – common lymphoid progenitors, MEP – megakaryocyte-erythroid progen-
itors, GMP – granulocyte-macrophage progenitors.
lated host. An HSC is often defined by the ability of a cell to support at least 1% 
lymphomyeloid chimerism in a recipient animal for 4 months post-transplan-
tation (18,19). Primitive cells contributing to peripheral blood cells less than 
1% are usually unable to sustain robust blood production in the long-term, or 
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ing dilutions of bone marrow cells (31), and in single-cell transplant recipients 
(8) demonstrated the presence of at least three distinct developmental types of 
behavior of HSCs. These studies established that individual cells can preferen-
tially support myeloid cell production (so-called α, or myeloid-biased HSCs), 
lymphoid cell development (γ or lymphoid—biased HSCs) or be equally prone 
to generate both lineages (β or balanced HSCs). High expression of CD150 
has been demonstrated to correlate with a myeloid potential of HSCs (32). 
Lymphoid-biased HSCs have been shown to have a relatively short lifespan and 
to exhaust readily upon secondary transplantation (33). On the contrary, my-
eloid-biased HSCs had the longest lifespan and the highest self-renewal capacity 
of all HSC types (33).
Distinct gene expression profiles appear characteristic to HSCs with distinct 
developmental programs. CD150 (SLAM) and SP profiling in phenotypically 
isolated HSCs allowed their sub-fractionation into lymphoid-biased and my-
eloid-biased subsets (34) (Box 1). Serial transplantation experiments revealed 
that a lower SPLSK CD150high population preferentially contributed to LT-HSC, 
MPP and CMPs (Figure 1), while upper SPLSK CD150low cells produced signifi-
cantly more CLPs. Micro-array analysis carried out on those two populations 
revealed that pathways involved in cell cycling and metabolism were highly 
activated in lymphoid-biased HSCs (34). 
During aging, the proportion of myeloid-biased HSCs in the bone marrow 
increases at the expense of lymphoid biased and balanced HSCs (34-37). Such 
an expansion of myeloid-primed HSCs is likely to result from a combination 
of higher self-renewal potential (35), different response to cytokines, and lower 
metabolic activity (34) of this population. Moreover, while the pool of young 
HSCs is largely quiescent, a substantially higher fraction of aged HSCs is cy-
cling (14,16,20,38) (Figure 1). 
CHANGES IN HOMING AND MIGRATION OF STEM CELLS UPON AGING
The ability to engraft bone marrow and to migrate throughout the body are es-
sential properties of HSCs that allow them to exit the fetal liver and repopulate 
bone marrow in the initial stages of development. Studies in 1960s demonstrat-
ed that a small number of repopulating cells is also present in the blood of mice 
in steady state conditions (39). These circulating cells are capable of reentering 
available HSC niches, as demonstrated by experiments with pairs of parabiotic 
mice that share their circulation (40) and by transplantation of bone marrow 
cells into non-irradiated recipients (41). Homing of cells to myeloablated or 
unmanipulated niches is a prerequisite in experimental or clinical bone marrow 
transplantations, where intravenous cell injection is sufficient for grafting and 
regeneration of hematopoietic system (42).
Several studies demonstrated that upon aging the engraftment and hom-
ing ability of HSCs decreases ~2-fold. Liang et al. demonstrated diminished 
short-term (24 hour) homing of old HSCs by limiting-dilution competitive 
transplantation of young and aged HSCs (22). Recently, our lab confirmed this 
observation by direct measurement of fluorescent cells in bone marrow after 
co-transplantation of HSCs isolated from old and young differentially colored 
transgenic donors (9).
On the contrary, levels of both mobilized progenitors and transplantable 
HSCs were ~ 5 fold higher in peripheral blood and spleen of granulocyte-colo-
ny stimulating factor (G-CSF) treated 25-month old mice compared to young 
3-month old animals (43). Xing et al. proposed that lower adhesion of aged 
HSCs to stromal cells and increased activity of small Rho GTPases that are 
involved in regulation thereof play a role in this change (43).
Interestingly, data generated in our lab demonstrates that on a clonal level 
young and aged HSCs are similar in their migratory behavior (79). When pu-
rified HSCs were labeled with DNA barcodes and transplanted into irradiated 
hosts, barcoded clones of both young and old HSCs were unequally distributed 
across the skeleton. However, administration of G-CSF led to redistribution 
of HSC around the skeleton. At the same time, clonal analysis demonstrated 
that the pool of old HSCs was composed of multiple small clones, whereas the 
young HSC pool contained fewer, but larger clones (80). 
The observed functional decline in aged HSCs is reflected in their transcrip-
tome and epigenome, which will be discussed in the next section. A final issue 
that we will discuss is how HSCs reside in an hypoxic environment, and how 
oxidative metabolism, production of reactive oxygen species (ROS) and DNA 
repair pathways are linked to diminished self-renewal and proliferative abilities 
of old HSCs.
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GENE EXPRESSION CHANGES
The increased number of HSCs in aged animals, accompanied by defects in 
their repopulating ability, as discussed above, suggests that changes in the tran-
scriptional and epigenetic landscape occur with time. However, data describing 
the transcriptome of old HSCs are limited (15,44,45, 81) and highly variable. 
Our understanding of the epigenome is even more restricted, with only 2 stud-
ies recently been published (46, 81). In this section, we will discuss molecular 
mechanisms of HSC aging identified thus far.
To date, three groups have independently used microarray analysis to com-
pare gene expression profile in young and aged HSCs. Categories of genes that 
were up-regulated with age in HSCs included those involved in NO-mediated 
signal transduction, stress response (protein folding), and the inflammatory re-
sponse. Age-dependent repressed genes were enriched for those involved in the 
preservation of genomic integrity, e.g. chromatin remodeling and DNA repair 
(15,47). Surprisingly, while results of all studies indicate that hundreds of genes 
are differentially expressed, only 5 of those genes were overlapping among these 
reports. Of note, all of these studies used pooled samples from multiple mice to 
initiate the analysis. While differences in the panel of markers used for selection 
of HSCs (Box 1) could contribute to such discrepancies, it is also likely that 
the pronounced heterogeneity of individual aged mice that we discussed above, 
can explain these differences. In the future, analysis of individual mice will be 
instrumental for answering this question. Nevertheless, below we will further 
discuss molecular players that were indicated in those and other studies.
Genes that have been found to be involved in HSC aging thus far, include 
receptors, chromatin modifiers, transcription factors, genes involved in the 
DNA damage response and cell proliferation. Two of the highly up-regulated 
genes involve the surface adhesion molecules P-selectin and Inter Cellular Ad-
hesion Molecule 1 (ICAM1) (Figure 3) (15,44). Increased levels of P-selectin 
and ICAM1 are implicated in a higher mobility of those cells and can interfere 
with HSCs engraftment in bone marrow, which is strictly dependent on adhe-
sion. Of these genes, P-selectin has been shown to serve as a marker for physio-
logical stress, including inflammation, and it is therefore interesting that it has 
now been shown to be activated upon aging. It mediates the leukocyte–vascu-
lar endothelium interaction involved in leukocyte extravasation, and therefore 
appears important for HSCs migration (48). At the same time, a decreased 
expression level of chromatin modifiers (SWI/SNF and PRC2 core members) 
implicates reorganization of the chromatin structure (44,46,49). Epigenetic 
perturbations may propagate skewing towards the myeloid lineage and be in-
volved in anemia in aged individuals, because of hypermethylation of promoter 
regions of genes regulating lymphopoiesis and erythropoiesis (46). 
Further, aged HSCs are likely to display a more euchromatic genome state, 
since genes encoding chromatin compaction tend to be down-regulated in old 
HSCs (besides the above-mentioned SWI/SNF remodellers, expression of re-
lated chromatin remodeling genes such as Smarca4 and Smarca1, as well as 
histone deacetylases Hdac-1, -5, and -6 and a DNA methyltransferase Dnmt3b 
is decreased) (44). 
Moreover, recent RNA-Seq-based report on epigenomic state of old HSCs doc-
uments an increased occurrence of the transcription activating mark-H3K4me3 
across self-renewal genes, decreased methylation of HSC maintenance genes 
combined with hypermethylation of gene promoters associated with differentia-
tion, reflecting phenotypical HSC ageing (81). Interestingly ribosomal biogene-
sis seems to be a particular target of aging with hypomethylation of rRNA genes.
Figure 3. Molecular mechanisms of murine HSC aging. The figure summarizes molecules/pathways 
reported to be changed in aged HSCs. Increased expression is shown with red arrows, and decreased 
expression with blue. Changes in cellular localization of Cdc42 are depicted: while in young cells it is 





















INTRODUCTION   ||   CHAPTER 2  | AGING OF HEMATOPOIETIC STEM CELLS IN THE MOUSE30 31
The expression of P-selectin, one of the few proteins to be consistently up-
regulated in aged HSCs, is regulated by NF-κB (the p65 isoform). In HSCs 
from aged mice it has been observed that p65 accumulates in the nucleus, in-
dicating transcriptional activation. Increased abundance of this protein in the 
nucleus of aged HSC may induce up-regulation of Toll-like receptor 4 (TLR-4), 
as well as higher levels of proinflammatory molecules in the plasma of aged in-
dividuals (50,51). Such higher levels of proinflammatory cytokines (TNFα, IL-
1β), together with increased expression of inflammation-related genes, support 
the concept of inflammation playing a significant role in the aging process (44).
Two other genes that have often been associated with the aging process 
are p16 Ink4a and p19Arf,which are tumor suppressors that induce loss of HSCs 
without inducing apoptosis (52). Furthermore, p16 Ink4a has been proposed as 
a biomarker of aging as its expression increases with age in mammalian tis-
sues, including murine bone marrow (53). The presence of p16Ink4a restricts the 
number of HSCs, and affects their serial repopulation capacity, cell cycling and 
apoptosis (54). However, a causal role for p16Ink4a in the aging process is still 
under discussion since an effective repression of this gene by H3K27me3 mark 
in young and old HSCs was recently reported (81). Moreover, in the study 
from Attema et al., no increased levels of p16Ink4a transcripts in individual aged 
HSCs were found (55). The expression of p16Ink4a and p19Arf is mediated by the 
activity of Polycomb Repressive Complex 2 (PRC2). A recent studies showed 
up-regulation of PRC2 core component in aged HSCs, suggesting in fact in-
creased repression of this locus upon aging (49,56). This is in line with findings 
that have shown hypermethylation of loci targeted by PRC2 during aging (46).
Aside from the possible, if not likely, contribution of epigenetic mechanisms 
underlying stem cell aging, there are also many studies that indicate a causal 
role of genetic and genomic alterations in the aging process. A decline in the 
expression of genes involved in DNA repair, resulting in an increased rate of 
non-repaired DNA damage, is thought to be a driving factor in aging. The role 
of these pathways is described in the next section.
THE ROLE OF OXIDATIVE METABOLISM AND DNA REPAIR IN 
HSC AGING
HSCs reside in the bone marrow and are supposed to replenish blood cell pro-
duction for the entire lifetime of the organism. Both cell-extrinsic localization 
and cell-intrinsic DNA damage repair mechanisms allow HSCs to maintain 
their functionality. HSCs appear not be lodging randomly in the bone marrow, 
but in fact preferentially reside in a low oxygen environment which: 1) reduc-
es molecular damage that results from oxidation by ROS, 2) determines their 
energy status, 3) induces pathways that are active under hypoxic conditions 
and 4) decreases the rate by which DNA mutations accumulate. Apart from 
preventing damage by avoiding exposure to oxygen, HSCs implement efficient 
mechanisms of DNA repair to remove deleterious mutations and prevent these 
to propagate to their progeny. To accomplish this ability, HSCs can employ two 
independent pathways, depending on the type of the DNA damage and their 
cell cycle status. We will discuss these parameters in more detail in this section.
One of the first concepts suggesting a link between ROS and the aging 
process is the ‘free radical theory of aging’, proposed by Harman in 1950`s (57). 
This theory argues that the effect of ROS on cellular components (proteins, nu-
cleic acids and lipids) may be key in determining the lifespan of the organism. 
Thus, if we consider that the lifespan of the organism is at least partially deter-
mined by the activity of stem cells to maintain tissue homeostasis, effective neu-
tralization of ROS may be crucial for maintaining the stem cell pool. Indeed, 
several recent studies have demonstrated a role of ROS, and how managing 
ROS levels and, more general, metabolism affect proper HSC functioning.
The redox potential in HSCs is strictly regulated by intrinsic and extrin-
sic factors that will be described later in detail. The average O2 concentration 
in BM is approximately three times lower compared to blood (58,59). This 
suggests that HSCs are residing in an environment with limited availability of 
oxygen, which propagates glycolytic metabolism (60). However the content of 
mitochondria in HSC is relatively high compared to myeloid cells which sug-
gest that they are less active (56).
Although the net production from 2 glucose molecules is only 2 ATP (ver-
sus 36 – 38 ATPs during mitochondrial oxidation), this metabolic landscape 
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is compatible with the low energy requirements of HSC (61) and significantly 
reduces the rate of ROS production. Whether ROS levels in HSCs are mainly 
determined by the niche location or by the stem cell-intrinsic activation status 
remains to be further investigated.
Several studies have shown that ROS levels increase with proliferation and 
during early steps of lineage commitment (60,62). These experiments have 
combined regular FACS staining for HSCs with DCF-DA, a probe enabling 
the measurement of ROS activity in viable cells. Using this approach allowed 
the identification of two populations of ROSlow and ROShigh stem cells. The 
population of ROShigh stem cells showed functional decline upon serial trans-
plantation and a typical pattern of differentiation skewing towards the myeloid 
lineage. This clearly mimics characteristics of aged HSCs. Moreover, these RO-
Shigh cells express activated p38 kinase and components of the mTOR pathway, 
both involved in stress response. Treatment of ROShigh HSCs with inhibitors of 
both of these pathways was able to restore functional activity (62). The com-
parison of the ratio of ROSlow versus ROShigh populations in aged mice showed 
a strong decline of cells expressing low levels of ROS, and only a moderate 
increase in the ROShigh population. Therefore, a decrease in ROSlow stem cells 
may be responsible for the skewing of myeloid differentiation and the impaired 
repopulating activity (62).
The major impact of oxidation on HSCs discussed above seems to be re-
flected also by the presence of O2 in the hematopoietic niche. Decreased oxygen 
availability activates Hypoxia Inducible Factor (HIF)-signaling, which regulates 
the redox potential in HSCs. The HIFs family of transcription factors com-
prises 4 proteins, among which HIF-1α is the best studied. HIF-1α levels are 
controlled by products of the Ink4a gene locus, and appears to play a protective 
role against senescence-induced HSCs exhaustion. Bone marrow cells deficient 
of HIF-1α showed increased ROS levels (63). Similar phenotype with HSC ex-
haustion and increase in ROS content was observed during deletion of subfami-
ly of transcription factors-Forkhead O (FoxOs 1,2,3,4) (64), which regulate the 
expression of genes involved in metabolism and oxidative stress (65). However 
the treatment of those cells with antioxidants partially rescued defects in HSCs 
deficient for these proteins (64). Thus, induction of cellular senescence may 
originate from ineffective ROS management, which on its turn may lead to 
DNA damage. Indeed, a recent study provides evidence directly linking cellular 
senescence with DNA damage (66).
In line with a detrimental influence of ROS on HSCs, it has been shown 
that endogenous DNA damage accumulates with age in normal stem cells. Mul-
tiple foci of phosphorylated γ- H2AX, a marker of DNA damage, were found in 
over 70% of old HSCs (15). However, the percentage of γ-H2AX positive cells 
decreases as the cell differentiated to more committed progenitors. The alter-
native explanation would be that γ- H2AX is a marker for impaired replication, 
and associated with stalled or collapsed replication forks. This hypothesis is in 
line with reduced expression of MDM helicase family genes that decline with 
age. Importantly, downregulation of members of this family in young HSCs 
led to their impaired engraftment-a feature characteristic of old HSCs (82). 
Furthermore, cellular mislocalization of PP4c (γ- H2AX phosphatase) in aged 
HSCs, leads to delayed and ineffective dephosphorylation and accumulation of 
γ- H2AX (82). This indicates that with age, DNA damage accumulates prefer-
entially in stem cells, while this is either repaired more quickly in proliferating 
progenitor cells, or DNA damage- containing progenitors are eliminated. This 
also reiterates the notion of cell type-dependent efficiency of DNA damage 
repair. In the next paragraph we will further discuss how mechanisms for DNA 
repair are implicated in HSC aging.
To repair DNA damage, cells utilize a repair machinery that is either DNA 
template- dependent or template-independent. So far, it has been shown that 
several template-dependent mechanisms of DNA damage repair are active in 
HSCs. All of these are negatively affected by aging. Such repair mechanisms in-
clude non-homologous end joining (NHEJ) which occurs during G0/G1 stages 
of cell cycle and nucleotide-excision repair (NER) utilized to remove modified 
nucleotides. The effect of aging on these processes have been assessed using 
mutant mouse models with defects in these pathways (67). Both XPDTTD mice, 
with deficiency of NER, and Ku80-/-animals, where NHEJ is affected, generat-
ed numbers of old HSCs comparable to normal mice, but their functionality 
was severely affected upon serial transplantation (68,69).
Interestingly, a similar phenotype was observed in mTR-/- mice, a mouse 
strain deficient for telomerase. Telomere shortening affected the intrinsic ability 
of HSCs to self-renew (68) and also limited the capacity of niche cells to support 
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HSC homing (70). The decline of HSCs activity in the absence of telomerase 
could be reverted by down-regulation of the DNA damage checkpoint – Basic 
leucine zipper Transcriptional Factor (BATF), which simultaneously resulted in 
accumulation of DNA damage in HSCs (71).
In the case of double stranded DNA breaks, template-independent DNA 
repair takes place. This requires the activity of the protein kinase Ataxia Telan-
giectasia Mutated (ATM). The analysis of ATM-/- HSCs revealed a lack of long-
term repopulating capacity (72). Moreover, on the molecular level, increased 
ROS levels (much higher than those observed in normal aged HSCs) contribut-
ed to up regulation of p16Ink4a and p19Arf in those cells (52,73). Malfunctioning 
of ATM-/- HSCs could be rescued by the long-term treatment of mice with 
the anti-oxidative molecule N- acetyl cysteine (NAC). This highlights the anti- 
-aging properties of ROS quenching antioxidants. Moreover, increased cellular 
ROS levels activate the p38 MAPK pathway (62,72), which inhibits quiescence 
state in Atm-/- HSCs (72).
A schematic overview of the molecular events implicated in HSC aging is 
provided in Figure 3. To summarize, adult HSCs accumulate DNA damage un-
der physiological conditions in vivo due to a plethora of intrinsic and extrinsic 
factors. The mechanisms that we describe above are relevant for neutralizing 
DNA damage in order to maintain the pool of HSCs; dysfunctioning of any of 
those pathways will inevitably cause HSCs exhaustion.
The functional and molecular changes that occur during aging in individual 
HSCs, impacts on the behavior of the entire hematopoietic stem cell pool, i.e. 
on how stem cells act in concert during the aging process. In the next section we 
will briefly discuss various currently prevailing stem cell aging models.
MODELS OF HSC AGING
Originally it was considered that the age-related decline in functioning of 
a  population of HSCs was caused by cellular aging of individual stem cells 
and involved a homogeneous HSC population (68,69). Such aging model was 
dubbed the “population shift model”. This model presumes that the HSC pop-
ulation is uniform and all cells gradually accumulate damage, lose their ability 
to produce lymphoid cells and to engraft bone marrow (74). Later, the identifi-
cation of distinct developmental programs of individual HSCs and observation 
of changes in the representation of these HSC subsets with age, led to estab-
lishment of an alternative hypothesis. This “clonal selection model” implied 
that changes in the clonal make-up of the HSC pool, rather than changes in 
individual HSCs underlie the hematopoietic aging (36,74). This theory also 
assumes that individual HSCs do not change with age (74). The most recent 
conceptual view on aging combines both models: a changing pool of HSCs is 
simultaneously affected by cellular aging (9,32).
PERSPECTIVES
Several other mechanisms that may contribute to functional hematopoietic de-
cline are currently being investigated. These include factors such as metabolism, 
epigenetic changes, polarity, the regulation of post-transcriptional gene expres-
sion and hematopoietic microenvironment. 
Metabolism. A recent paper reports an increased activation of the mTOR 
pathway in HSCs and progenitors from aged mice (75). Administration of rapa-
mycin (the inhibitor of mTOR pathway) limited the age-related expansion of 
the HSC pool, and also improved their functionality so that these aged HSCs 
became as effective as young HSCs (75). It has also been shown that autophagy 
is increased in old HSCs and ensures their survival (83). Additionally, loss of 
expression of the nutrient sensing protein SIRT7 with age, has been associated 
with increased HSC proliferation and skewing of hematopoiesis towards pro-
duction of myeloid cells (84). 
Non-coding RNAs. Furthermore non-coding RNAs seem to play a pivotal 
role in the aging process. In the study from Boon et al., authors studied the role 
of microRNAs (miRNA) in aged cardiomyocytes. MiR-34a, by suppressing the 
expression of its targets, leads to inhibition of telomere erosion, DNA dam-
age response and apoptosis (76). It leaves the ground for speculation, that also 
during HSC aging certain miRNAs play an important role in determining their 
functionality and moreover specifying the cellular program to preferentially dif-
ferentiate into certain lineages. No data on miRNA functioning in aged HSCs 
are currently available. However, a recent report documents the importance 
and the potential of long non-coding (Lnc-RNAs) in regulating self-renewal 
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and lineage-commitment in old HSCs (Luo et al., 2015). Two lnc-RNAs (re-
ferred to as LncHSC-1 and LncHSC-2) affect lineage commitment. Whereas 
downregulation of LncHSC-1 led to myeloid skewing at the expense of B cells, 
LncHSC-2 promoted T lymphopoiesis (85). 
Cell polarity. Recent studies have demonstrated that polar localization of 
the small Rho-GTPase Cdc42 is characteristic for young HSC (but not more 
committed cells) and this polarity is lost with age due to increased activity of 
Cdc42.(77). The shift from canonical to noncanonical Wnt signaling has been 
associated with apolar Cdc42 cellular localization (86). Remarkably, adminis-
tration of a chemical compound (a CASIN inhibitor), allowed restoration of 
both polarity and functionality of old cells, and resulted in their rejuvenation 
(77). Similarly reduced non-canonical Wnt5a signaling in old HSCs rejuve-
nates chronologically aged HSCs and restores polar localization of Cdc42 (86). 
The prospect that we may indeed be able to rejuvenate aged stem cells is of 
considerable interest for future clinical interventions.
Microenvironment. Finally, while this chapter focuses on cell-intrinsic 
mechanisms of HSC aging, recent findings indicate the potential contribution 
of the bone marrow microenvironment, or “niche”, to HSC aging phenotype. 
To support this notion, the level of inflammatory cytokine CCL5 that is shown 
to induce myelopoiesis at expense of lymphopoiesis, was shown to increase 
upon aging (87). It was also demonstrated that localization of hematopoietic 
progenitors in old bone changes further from endosteum and is associated with 
reduced cell polarity (88). A recent report also highlights the role of p19INK4d 
in niche remodeling upon aging (89). The authors argue that loss of p19INK4d 
in microenvironment with age results in expansion of myeloid-biased HSCs, 
possibly through changes of expressed levels of TGF-β1 by the niche cells (89). 
Therefore, it is likely that HSC aging is a complex interplay between changes in 
the HSC pool itself and the aging environment they reside in.
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